Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 19 - Hybrid peptides
Patents for C07K 19 - Hybrid peptides (29,428)
08/2003
08/21/2003US20030158399 Compositions and methods for the treatment and diagnosis of immune disorders
08/21/2003US20030158390 Protein; Escherichia culture product; genetic engineering; fusion
08/21/2003US20030158099 Cancer therapy
08/21/2003US20030157599 Comprises nucleotide sequence coding prostaglandin E receptor (EP3) for diagnosis and treatment of atherosclerotic diseases; restriction fragment length polymorphisms
08/21/2003US20030157479 Antigen arrays for treatment of allergic eosinophilic diseases
08/21/2003US20030157124 Chlamydia membrane ATPase and corresponding DNA molecules, which can be used to prevent and treat Chlamydia infection in mammals such as humans
08/21/2003US20030157099 Human trk receptors and neurotrophic factor inhibitors
08/21/2003US20030157096 Used to antagonize the effects of T-cell inducible factor in certain diseases
08/21/2003US20030157090 Redox systems; accumulation of polypeptide in plant cell; genetic engineering
08/21/2003US20030157055 Modified cytokines for use in cancer therapy
08/21/2003CA2816242A1 Signal for packaging of influenza virus vectors
08/21/2003CA2752553A1 Anti-cd20 antibodies and fusion proteins thereof and methods of use
08/21/2003CA2482633A1 Oligomeric molecules and uses thereof
08/21/2003CA2476239A1 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
08/21/2003CA2475388A1 Chimeric molecules for cleavage in a treated host
08/21/2003CA2475177A1 Materials and methods for preparing dimeric growth factors
08/20/2003EP1335976A2 Modifier of organelle metalbolism
08/20/2003EP1335938A2 Apolipoprotein analogues
08/20/2003EP0324789B1 Methods of regulating metabolic stability of proteins
08/20/2003CN1437655A Assembly of wild-type and chimeric influenza virus-like particles (VLPS)
08/20/2003CN1437653A Antigenic polypeptides
08/20/2003CN1437652A Compounds and methods for treatment and diagnosis of chlamydial infection
08/20/2003CN1118572C G-CSF analogue compisition, and preparing process thereof
08/20/2003CN1118474C Synthetic peptides and vaccines containing the same
08/19/2003US6608031 Peptide comprising specified amino acid sequence
08/19/2003US6607730 Chlamydia antigens and corresponding DNA fragments and uses thereof
08/19/2003US6607728 Compounds and methods for the diagnosis and treatment of ehrlichia infection
08/19/2003CA2122613C Targeted delivery of virus vector to mammalian cells
08/14/2003WO2003066859A2 Amino acid sequences capable of facilitating penetration across a biological barrier
08/14/2003WO2003066824A2 Albumin-fused kunitz domain peptides
08/14/2003WO2003066660A2 A PAIR OF ANTIBODY Fv FRAGMENTS STABILIZED BY COILED­COIL PEPTIDES
08/14/2003WO2003066611A1 Bioluminescent protease assay
08/14/2003WO2003066085A1 Albumin-fused anti-angiogenesis peptides
08/14/2003WO2003066078A1 Hiv inhibiting proteins
08/14/2003WO2003066003A2 Anti-pathogen treatements
08/14/2003WO2003065973A2 Multivalent streptococcal vaccine compositions and methods for use
08/14/2003WO2003032898A3 Modified human thymic stromal lymphopoietin
08/14/2003WO2002099108A3 Atp-binding cassette transporter-like molecules and uses thereof
08/14/2003WO2002026779A3 A fibrin/fibrinogen-binding conjugate
08/14/2003WO2002024887A3 Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen
08/14/2003WO2002024735A3 Peptide inhibitors of hiv entry
08/14/2003WO2002014351A3 α7 NICOTINIC RECEPTOR PEPTIDES AS LIGANDS FOR β AMYLOID P EPTIDES
08/14/2003WO2002008288A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/14/2003US20030154509 Control of gene expression in plants
08/14/2003US20030153727 Controlling protein levels in eucaryotic organisms
08/14/2003US20030153518 Activation and inhibition of the immune system
08/14/2003US20030153490 Insulin conjugates and methods of use thereof
08/14/2003US20030152526 Bovine milk growth factor
08/14/2003CA2485064A1 Albumin-fused kunitz domain peptides
08/14/2003CA2475539A1 Hiv inhibiting proteins
08/14/2003CA2475382A1 Albumin-fused anti-angiogenesis peptides
08/14/2003CA2475247A1 Anti-pathogen treatments
08/14/2003CA2474695A1 Bioluminescent protease assay
08/14/2003CA2474283A1 Amino acid sequences capable of facilitating penetration across a biological barrier
08/14/2003CA2464527A1 Multivalent streptococcal vaccine compositions and methods for use
08/13/2003EP1334984A1 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
08/13/2003EP1334980A1 Multimerized highly functional antifreeze protein
08/13/2003EP1334187A2 C. elegans genes involved in viability and/or reproduction and uses thereof
08/13/2003EP1334123A2 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases
08/13/2003EP1334117A1 Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane-associating elements
08/13/2003EP1333857A2 IMMUNOGENIC HBc CHIMER PARTICLES HAVING ENHANCED STABILITY
08/13/2003EP1333853A1 Growth factor complex
08/13/2003EP0531472B1 Humanized monoclonal antibodies
08/13/2003CN1436234A Composition and methods for therapy and diagnosis of prostate cancer
08/13/2003CN1435485A Recombinant DNA sequence, coded immune fusion protein and expression method
08/13/2003CN1435433A Long-acting broad-spectrum chemotactic factor receptor inhibiting matter
08/13/2003CN1435427A Recombinant human alpha-prothymosin interleukin 2 gene and its expression and use
08/13/2003CN1117764C Gene engineering immune toxin of anti-carcinoma of bladder and its prodn. process
08/13/2003CN1117760C Lysosomal enzyme-cleavable antitumor drug conjugates
08/12/2003US6605706 Gene expressing polypeptide in prokaryotic cells; harvesting, solubilizing cells in buffer with chaotropic and reducing agents; dilution
08/12/2003US6605697 Modified E. coli enterotoxin II signal peptide and a microorganism expressing a fusion protein of a said peptide and a heterologous protein
08/12/2003US6605464 Expressible polynucleotides encoding eukaryotic heat shock proteins
08/12/2003US6605443 Drug screening for compound which disrupts Smad7 transforming growth-beta factor superfamily signal transduction inhibitory activity
08/12/2003US6605280 Interleukin-18 binding proteins, their preparation and use for blocking the activity of IL-18
08/12/2003US6605279 Nucleotide sequences coding preferential polypeptide for use in intensifying immunological response
08/07/2003WO2003064992A2 Novel immunoadhesins for treating and preventing toxicity and pathogen-mediated diseases
08/07/2003WO2003064660A1 Hybrid plasmid pzzsa coding the synthesis of angiogenin protein and escherichia coli bl21 (des) pzzsa strain as the superproducer of the recombinant chimeric protein of human angiogenin
08/07/2003WO2003064656A1 Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state
08/07/2003WO2003064629A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/07/2003WO2003064614A2 Transport peptides and uses therefor
08/07/2003WO2003064613A2 Amidases, nucleic acids encoding them and methods for making and using them
08/07/2003WO2003064609A2 Targeted immunogens
08/07/2003WO2003064471A2 Gene for peripheral arterial occlusive disease
08/07/2003WO2003064468A2 The ligand binding pocket peptide fragment of estrogen-related receptor 3 (err3), its crystal structure, and uses thereof
08/07/2003WO2003064467A1 A complex of a human foxc2 protein and a foxc2-interacting protein
08/07/2003WO2003063910A2 β-HOMOLYSINE CONJUGATES AND THEIR USE AS TRANSPORT ENHANCER
08/07/2003WO2003052091A8 Growth factor modified protein matrices for tissue engineering
08/07/2003WO2002046386A3 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase
08/07/2003WO2002004015A9 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use
08/07/2003WO2002002593A3 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof
08/07/2003US20030149247 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells
08/07/2003US20030149246 Macromolecular conjugates and processes for preparing the same
08/07/2003US20030149237 G-protein coupled receptor for treatment and prevention of eating, cancer, autoimmune, vision and nervous sytem disorders; antiinflammatory agents
08/07/2003US20030148456 Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins
08/07/2003US20030148451 Endothelial differntiation gene 6-like g protein coupled receptor
08/07/2003US20030148446 Acute neuronal induced calcium binding protein type 1 ligand
08/07/2003US20030148420 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase
08/07/2003US20030148409 Genetically engineered monoclonal di/tri/tetra antibodies preferential tumor associated antigens for use in diagnosis and treatment of tumors
08/07/2003US20030148408 Compositions and methods for the diagnosis and treatment of tumor
08/07/2003US20030148382 PanCAM nucleic acids and polypeptides
1 ... 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 ... 295